Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals Share Holder Equity 2010-2023 | IRWD

Ironwood Pharmaceuticals share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
  
Ironwood Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2023 $-346
2022 $652
2021 $606
2020 $63
2019 $-93
2018 $-196
2017 $10
2016 $67
2015 $95
2014 $89
2013 $38
2012 $144
2011 $110
2010 $160
2009 $-298
Ironwood Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $-346
2023-09-30 $-326
2023-06-30 $-347
2023-03-31 $707
2022-12-31 $652
2022-09-30 $591
2022-06-30 $533
2022-03-31 $518
2021-12-31 $606
2021-09-30 $580
2021-06-30 $512
2021-03-31 $110
2020-12-31 $63
2020-09-30 $6
2020-06-30 $-37
2020-03-31 $-72
2019-12-31 $-93
2019-09-30 $-153
2019-06-30 $-219
2019-03-31 $-237
2018-12-31 $-196
2018-09-30 $-197
2018-06-30 $-44
2018-03-31 $-18
2017-12-31 $10
2017-09-30 $-18
2017-06-30 $5
2017-03-31 $30
2016-12-31 $67
2016-09-30 $59
2016-06-30 $81
2016-03-31 $91
2015-12-31 $95
2015-09-30 $100
2015-06-30 $140
2015-03-31 $68
2014-12-31 $89
2014-09-30 $108
2014-06-30 $142
2014-03-31 $189
2013-12-31 $38
2013-09-30 $84
2013-06-30 $139
2013-03-31 $59
2012-12-31 $144
2012-09-30 $182
2012-06-30 $129
2012-03-31 $164
2011-12-31 $110
2011-09-30 $113
2011-06-30 $130
2011-03-31 $145
2010-12-31 $160
2010-09-30 $168
2010-06-30 $174
2010-03-31 $189
2009-12-31 $-298
2009-09-30 $-276
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.039B $0.443B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.263B 32.23
Chugai Pharmaceutical (CHGCY) Japan $51.982B 23.24
Takeda Pharmaceutical (TAK) Japan $42.124B 8.53
Merck (MKGAF) Germany $23.587B 22.87
Astellas Pharma (ALPMY) Japan $17.518B 27.66
Sandoz Group AG (SDZNY) Switzerland $15.512B 0.00
Neurocrine Biosciences (NBIX) United States $14.281B 39.09
Shionogi (SGIOY) Japan $13.629B 11.85
United Therapeutics (UTHR) United States $12.075B 12.87
Catalent (CTLT) United States $9.999B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.716B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.965B 7.66
Revolution Medicines (RVMD) United States $6.433B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.491B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.628B 0.00
Alpine Immune Sciences (ALPN) United States $4.456B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.094B 0.00
Summit Therapeutics (SMMT) United States $3.166B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.105B 0.00
Corcept Therapeutics (CORT) United States $2.867B 25.98
PTC Therapeutics (PTCT) United States $2.610B 0.00
Dyne Therapeutics (DYN) United States $2.512B 0.00
Indivior (INDV) United States $2.391B 11.33
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.946B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.937B 18.85
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.804B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.532B 0.00
Soleno Therapeutics (SLNO) United States $1.526B 0.00
Pacira BioSciences (PCRX) United States $1.467B 13.94
Xencor (XNCR) United States $1.385B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.335B 0.00
4D Molecular Therapeutics (FDMT) United States $1.326B 0.00
Cronos Group (CRON) Canada $1.154B 0.00
Enliven Therapeutics (ELVN) United States $1.120B 0.00
Collegium Pharmaceutical (COLL) United States $1.102B 6.59
Cassava Sciences (SAVA) United States $1.034B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.012B 0.00
Ocular Therapeutix (OCUL) United States $0.971B 0.00
USANA Health Sciences (USNA) United States $0.924B 15.11
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
ProKidney (PROK) United States $0.869B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.823B 0.00
Sage Therapeutics (SAGE) United States $0.723B 0.00
Lyell Immunopharma (LYEL) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.656B 0.00
Savara (SVRA) United States $0.652B 0.00
Altimmune (ALT) United States $0.631B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.572B 0.00
Siga Technologies (SIGA) United States $0.562B 7.18
Verve Therapeutics (VERV) United States $0.536B 0.00
OmniAb (OABI) United States $0.533B 0.00
Bioventus (BVS) United States $0.525B 20.09
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.491B 0.00
Esperion Therapeutics (ESPR) United States $0.491B 0.00
Heron Therapeutics (HRTX) United States $0.485B 0.00
Korro Bio (KRRO) United States $0.475B 0.00
Larimar Therapeutics (LRMR) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Lexeo Therapeutics (LXEO) United States $0.462B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.378B 71.25
Nanobiotix S.A (NBTX) France $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Fractyl Health (GUTS) United States $0.320B 0.00
Xeris Biopharma Holdings (XERS) United States $0.299B 0.00
Aquestive Therapeutics (AQST) United States $0.299B 0.00
Black Diamond Therapeutics (BDTX) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.58
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Pyxis Oncology (PYXS) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.243B 0.00
Akebia Therapeutics (AKBA) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.238B 0.00
Prelude Therapeutics (PRLD) United States $0.235B 0.00
Conduit Pharmaceuticals (CDT) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
CytoDyn (CYDY) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.172B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Elite Pharmaceuticals (ELTP) United States $0.148B 13.90
OptiNose (OPTN) United States $0.146B 0.00
Context Therapeutics (CNTX) United States $0.135B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.108B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
SCYNEXIS (SCYX) United States $0.091B 1.28
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.079B 0.00
Protara Therapeutics (TARA) United States $0.077B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.057B 0.00
Inotiv (NOTV) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Nutriband (NTRB) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
DURECT (DRRX) United States $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.96
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.44